Pandion Therapeutics, Inc. PAND
We take great care to ensure that the data presented and summarized in this overview for Pandion Therapeutics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in PAND
Top Purchases
Top Sells
About PAND
Insider Transactions at PAND
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2021
|
Eric D Larson Vice President, Finance |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
22,125
-100.0%
|
$1,327,500
$60.0 P/Share
|
|
Apr 01
2021
|
Jill Carroll Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
5,674,221
-100.0%
|
$340,453,260
$60.0 P/Share
|
|
Apr 01
2021
|
Donald Frail Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
61,113
-100.0%
|
$3,666,780
$60.0 P/Share
|
|
Apr 01
2021
|
Nancy Stagliano Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
73,067
-100.0%
|
$4,384,020
$60.0 P/Share
|
|
Apr 01
2021
|
Nancy Stagliano Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,000
-100.0%
|
$60,000
$60.0 P/Share
|
|
Apr 01
2021
|
John Sundy Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
115,826
-100.0%
|
$6,949,560
$60.0 P/Share
|
|
Apr 01
2021
|
Daniel J. Becker Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,827,883
-100.0%
|
$169,672,980
$60.0 P/Share
|
|
Apr 01
2021
|
Daniel J. Becker Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,000
-100.0%
|
$60,000
$60.0 P/Share
|
|
Apr 01
2021
|
Christopher Fuglesang Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,131,135
-100.0%
|
$127,868,100
$60.0 P/Share
|
|
Apr 01
2021
|
Rahul Kakkar Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
702,515
-100.0%
|
$42,150,900
$60.0 P/Share
|
|
Apr 01
2021
|
Rahul Kakkar Chief Executive Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
14,000
-100.0%
|
$840,000
$60.0 P/Share
|
|
Apr 01
2021
|
Gregg Beloff Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
13,196
-100.0%
|
$791,760
$60.0 P/Share
|
|
Apr 01
2021
|
Edward D. Freedman Chief Operating Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
54,460
-100.0%
|
$3,267,600
$60.0 P/Share
|
|
Apr 01
2021
|
Alan L Crane Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
3,537,736
-100.0%
|
$212,264,160
$60.0 P/Share
|
|
Apr 01
2021
|
Alan L Crane Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
84,158
-100.0%
|
$5,049,480
$60.0 P/Share
|
|
Apr 01
2021
|
Vikas Goyal Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
87,764
-100.0%
|
$5,265,840
$60.0 P/Share
|
|
Apr 01
2021
|
Joanne L. Viney Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,200
-100.0%
|
$72,000
$60.0 P/Share
|
|
Apr 01
2021
|
Joanne L. Viney Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
503,254
-100.0%
|
$30,195,240
$60.0 P/Share
|
|
Nov 19
2020
|
Daniel J. Becker Director |
BUY
Open market or private purchase
|
Indirect |
197,716
+6.53%
|
$2,965,740
$15.12 P/Share
|
|
Nov 18
2020
|
Daniel J. Becker Director |
BUY
Open market or private purchase
|
Indirect |
14,197
+0.54%
|
$212,955
$15.26 P/Share
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders